All cards Flashcards
<p><span>What are 3 features unique to gram-negative bacteria?</span></p>
<ol>
<li><span>thin peptidoglycan (PG)</span></li>
<li><span>Safranin (red)</span></li>
<li><span>outer lipid rich membrane + lipoproteinsrepel many drug: polar drugs enter through porins to access PG</span></li>
</ol>
<p><span>Which is easier for a drug to penetrate- gram positive or negative bacteria, and why?</span></p>
<p><span>Gram positive, low MW enter easily across exposed PG layer, itself a key target</span></p>
<p><span>How does the murein (peptidoglycan) layer differ between gram positive and negative bacteria?</span></p>
<p><span>Gram positive: thick PG</span></p>
<p><span>Gram negative: thin PG</span></p>
<p><span>How does gram staining distinguish between gram positive and negative bacteria?</span></p>
<p><span>Gram<u> p</u>ositive:<u>p</u>urple dye</span></p>
<p><span>Gram negative: safranin (red)</span></p>
<p><span>Ribosomes and cell walls are common targets for antibiotics – which is unique to bacteria, and which is slightly different from its human counterpart?</span></p>
<p><span>bacteria vs humans:</span></p>
<ul>
<li><span>cell wall (humans have no cell walls) </span></li>
<li><span>70Sribosome (humans: 80S)</span></li>
<li><span>outer membrane (gram negative only)</span></li>
<li><span>Different needs for substrates</span></li>
</ul>
<p></p>
<p><span>What are the differences between bactericidal and bacteriostatic antibiotics, and which one requires a competent immune system to resolve the infection?</span></p>
<p><span>Bactericidal: kills bacteria; irreversible (penicillin)</span></p>
<p><span>Bacteriostatic: prevent replication; reversible (tetracycline) - the patient’s own immune system must deal with getting rid of rest of the infection</span></p>
<p><span>Describe 3</span><span><u>(there are 4 in the lecture)</u></span><span><u></u></span><span>categories of adverse effects of antibiotics – which is specific to antibiotics?</span></p>
<ol><li><span><u>Direct toxicity</u>: aminoglycosides generate free radicals that damage neurons in inner ear</span></li><li><span><u>Allergic reactions</u>: rapid, immune-mediated development of rash, hives</span></li><li><span><u>Idiosyncratic reactions</u>: hemolysis in G-6-PD-deficient patients treated with sulfonamides</span></li><li><span><u>Changes in normal body flora</u>: killing some bacteria allows other to proliferate; vaginal yeast infections<strong>(this is specific to antibiotics)</strong></span></li></ol>
<p><span>Contrast between prophylactic, pre-emptive, empiric and definitive / directed therapy.</span></p>
<p><span><u>Prophylactic</u>: antibiotic used before an infection</span></p>
<p><span><u>Pre-emptive therapy</u>: antibiotic used during symptoms occur to prevent anticipated infection or symptoms</span></p>
<p><span><u>Empiric therapy</u>: selection of an antibiotic based on<strong>most likely</strong> cause of infection</span></p>
<p><span><u>Definitive/directed therapy</u>: selection of an antibiotic based on<strong> positive identification</strong> of the causative organisms</span></p>
<p><span>Define the terms “sensitivity”, “MIC”, and “clinical breakpoint”</span></p>
<p><span><u>Sensitivity</u>: the ability of a bacteria to be inhibited/killed by a particular antibiotic; drug affects the bacteria at<strong>lowest concentration</strong> is the one to which it’s<strong>most sensitive</strong></span></p>
<p><span><u>Minimum inhibitory concentration (MIC)</u>: lowest concentration of drug that<strong>inhibits</strong>growth of organism</span></p>
<p><span><u>Clinical breakpoint</u>: highest plasma concentration that can safely be achieved in a patient</span></p>
<p><span>What is the purpose of broth dilution and disk diffusion testing?</span></p>
<p><span><u>Broth dilution</u>: bacteria in<strong> liquid</strong> are exposed to<strong>increasing concentrations</strong> of a drug - the lowest concentration that eliminates growth is MIC</span></p>
<p><span><u>Disk diffusion</u>: bacteria are plated onto<strong>agar studded</strong> with small disks containing<strong>different antibiotics</strong> - if bacteria surrounding a disk are dead, they are susceptible to that drug</span></p>
<p><span>How are MIC and breakpoint concentrations used together to determine bacterial sensitivity?</span></p>
<p><span><u>Sensitive</u>: MIC < breakpoint</span></p>
<p><span><u>Intermediate</u>: MIC near breakpoint</span></p>
<p><span><u>Resistant</u>: MIC > breakpoint</span></p>
<p><span>Contrast between the terms “broad spectrum” and “narrow spectrum” – why would a narrow spectrum drug sometimes be more appropriate?</span></p>
<p><span><u>Broad spectrum</u>: active against many types of bacteria</span></p>
<p><span><u>Narrow spectrum</u>: active against only one or a few types of bacteria (might be more appropriate: to<strong>kill/inhibit only unwanted</strong> bacteria; lessen resistance)</span></p>
<p><span>Contrast between time- and concentration-dependent antibiotic effects, and the dosing strategy required for each – give an example drug for each.</span></p>
<p><span><u>Time dependent</u>: constant rate of killing, provided that drug concentration exceeds MIC (beta lactams)</span></p>
<p><span><u>Concentration-dependent</u>: rate of killing increase with drug concentration above MIC (aminoglycosides)</span></p>
<p><span>State 3 advantages of combining antibiotic drugs - are all combinations of antibiotics equally beneficial, or can some be detrimental?</span></p>
<ol><li><span><strong>both MOA</strong> to produce a<strong>synergistic</strong> effect (greater than sum of individual drugs), in some cases combined antibiotics can<strong>antagonize</strong> each other’s effects</span></li><li><span>Combining antibiotics can also<strong>minimize risk of resistance</strong> development</span></li><li><span><strong>Lower doses</strong> of each agent can be used,<strong>minimizing side effect severity</strong></span></li></ol>
<p><span>What is the difference between intrinsic and acquired resistance?</span></p>
<p><span><u>Intrinsic:</u> trait that confers protection against antibiotic action, shared by all members of a bacterial species, not related to antibiotic exposure</span></p>
<p><span><u>Acquired</u>: certain gene changed become favored as a result of pressure from antibiotic exposure</span></p>
<p><span>What are 4 general mechanisms by which bacteria can become resistant to antibiotics, and which one of these is specific to gram negative bacteria?</span></p>
<ol><li><span><u>Altered receptors or targets</u> so drugs cannot bind (vancomycin)</span></li><li><span><u>Drug destruction</u> or inactivation (beta lactams)</span></li><li><span><u>New resistant pathway</u> (sulfonamides)</span></li><li><span><u>Decreased drug exposure</u>: less uptake/more efflux (regulating outer membrane pore function, or efflux transporter expression) - this mechanism is relevant to</span><span> gram negative</span><span> bacteria</span></li></ol>
<p><span>Can more than one resistance mechanism appear in the same strain of bacteria?</span></p>
<p><span>With in same species of bacteria, there may be multiple strains with varying types of resistance</span></p>
<p><span>A single species may have multiple acquired resistance mechanisms</span></p>
<p><span>What are the 3 main modes of horizontal transfer of acquired resistance, and how does each work?</span></p>
<ol><li><span><u>Transformation</u>: uptake of naked DNA containing resistance genes</span></li><li><span><u>Transduction</u>: DNA transferred by infection with viruses</span></li><li><span><u>Conjugation</u>: DNA transfer between bacterial cells via plasmid exchange</span></li></ol>
<p><span>Are resistance genes always acquired horizontally (from another organism)?</span></p>
<p><span>Bacterial<strong>proliferation</strong> and<strong>transfer</strong> between hosts (poor hygiene, hospital acquired infections)</span></p>
<p><span>Increased<strong>exposure</strong> of bacteria to<strong>antibiotics</strong> -> selection pressure (over prescription, wrong prescription, use in agriculture)</span></p>
<p><span>What is “antibiotic stewardship”?</span></p>
<p><span>coordinated data-driven programs that focus on reducing inappropriate antibiotic use in clinical settings and agriculture</span></p>
<p><span>What are two general categories of initiatives that are being supported to combat drug resistance development?</span></p>
<ol><li><span>Government</span></li><li><span>WHO, World Bank</span></li></ol>
<p>What are the 4 major classes of beta lactam antibiotics, and how can one recognize names of drugs in each class?</p>
<p>Penicillins: (-cillin)<br></br>Cephalosporins: (-cef-)<br></br>Carbapenems: (-penem)<br></br>Monobactams (aztreonam)</p>
What are the 4 major classes of penicillins?
<ul><li>Natural Penicillins:<ul><li>Penicillin G</li><li>Penicillin V</li></ul></li><li>Anti-staphylococcal:<ul><li>Nafcillin and Oxacillin</li><li>Dicloxacillin</li></ul></li><li>Amino/ Broad spectrum:<ul><li>Ampicillin</li><li>Amoxicillin</li></ul></li><li>Extended Spectrum:<ul><li>Piperacillin + tazobactam</li></ul></li></ul>
<p><span>Name 4 examples of beta lactamase inhibitor drugs.</span></p>
<ul><li><span>Clavulinic Acid</span></li><li><span>Sulbactam</span></li><li><span>Tazobactam</span></li><li><span>Avibactam</span></li></ul>
<p><span>What feature is shared in the names of all glycopeptide antibiotics?</span></p>
<p>-van-</p>
<p><span>Name the classes (and the 2 additional “other” drugs) that target bacterial cell membranes.</span></p>
<ul><li><span>Other cell wall antibiotics: fosfomycin, bacitracin</span></li><li><span>Lipopeptides: dapotomycin</span></li><li><span>Polymyxins (-myxin)</span></li></ul>
<p><span>Name 2 drugs that primarily target bacterial cell membranes.</span></p>
<p><span>Daptomycin: disrupts cytoplasmic membrane</span></p>
<p><span>Polymyxins: disrupt the outer membrane + cytoplasmic membrane</span></p>
<p><span>What are the two major components of peptidoglycan?</span></p>
<p><span><u>Polysaccharides</u>: 2 alternating sugars - N-acetylglucosamine (G) and N-acetylmuramic acid (M)</span></p>
<p><span><u>Peptides:</u> five amino acid chain, linked N-acetylmuramic acid sugar</span></p>
<p><span>What are the 3 major steps in PG synthesis – what happens in each step?</span></p>
<p><span><u>Monomer synthesis & transport:</u> in cytoplasm, building blocks are made from amino acids & sugar by enzyme (Mur enzyme), then transported to the cell surface by lipid carriers.</span></p>
<p><span><u>Glycan polymerization:</u> at cell surface, N and M sugars are connected into strands via transglycosylation by penicillin binding proteins (PBPs)</span></p>
<p><span><u>Polymer cross-linking</u>: strands are linked by transpeptidation, when penicillin binding proteins (PBPs) remove the peptide’s terminal D-alanine to cross-link it to another peptide</span></p>
<p><span>What are the roles of PBP (both roles), Mur enzymes, and flippase II enzymes?</span></p>
<p><span><u>PBP</u> often have both<strong>transpeptidase</strong> domain and<strong> glycosyltransferase</strong> domain</span></p>
<p><span><u>Mur A enzyme</u>:<strong>building blocks made</strong> from amino acids and sugar</span></p>
<p><span><u>Flippase II enzyme</u>s:<strong>transport</strong>building blocks to cell surface</span></p>
<p><span>Which steps in the PG synthesis pathway are targeted by: β lactams, glycopeptides, fosfomycin and bacitracin - and to what target does each one bind?</span></p>
<p>Photo attached below</p>
<p><span>What are 2 drugs that target the cell<u>membrane</u>, and how does each work?</span></p>
<p><span>Daptomycin: disrupts cytoplasmic membrane</span></p>
<p><span>Polymyxins: disrupt the outer membrane + cytoplasmic membrane</span></p>
<p><span>What are the 4 primary mechanisms by which bacteria become resistant to β lactam drugs?</span></p>
<ol><li><span><strong>Inactivation of antibiotic</strong> by bacterial<strong>beta-lactamase: </strong>these enzyme catalyzed<strong>opening</strong> of the antibiotic’s<strong>beta-lactam ring</strong></span></li><li><span><u>Reduced uptake of antibiotic</u>: specific to<strong>gram-negative</strong> bacteria (impervious<strong>outer membrane</strong>)</span></li><li><span><u>Antibiotic efflux</u>:<strong>gram negative bacteria</strong> may produce<strong>drug efflux pumps</strong> which toss some beta-lactam antibiotics back out</span></li><li><span><u>Alteration of the antibiotic’s target</u>: bacteria produce slightly different PBPs that antibiotics can’t bind to: development of a<strong>new PBP (PBP2a)</strong> by S. aureus is how the “superbug”<strong>MRSA</strong> arose</span></li></ol>
<p><span>Which of the 4 mechanisms of how bacterial resistance develops against cell wall / membrane-targeted agents is the most common?</span></p>
<p><span><strong>Inactivation of antibiotic</strong> by bacterial<strong>beta-lactamase</strong></span></p>
<p><span>What is the function of bacterial beta lactamase enzymes?</span></p>
<p><span>they protect beta-lactam antibiotics from ring-destruction (counter-defense)</span></p>
<p><span>What type of bacteria are more likely to develop antibiotic resistance by altering drug uptake / efflux – gram positive or negative (and why)?</span></p>
<p><span>Gram negative. They have an impermeable outer membrane.</span></p>
<p><span>Example: development of a<strong>new PBP (PBP2a)</strong> by S. aureus is how the “superbug”<strong>MRSA</strong> arose</span></p>
<p><span>Give 3 examples of how bacteria can develop antibiotic resistance by altering antibiotic<u>binding targets</u>.</span></p>
<ol><li><span>these enzymes catalyze opening of the antibiotic’s beta-lactam ring</span></li><li><span>most but not all bacteria produce beta-lactamase enzyme to defend themselves from antibiotics</span></li><li><span>bacteria make hundreds of different beta-lactamase enzymes, each degrades a particular range of beta-lactam antibiotics</span></li></ol>
<p><span>What is the mechanism by which MRSA developed resistance to penicillins?</span></p>
<p>Alteration of the antibiotic’s target: bacteria produce slightly different PBPs that antibiotics can’t bind to</p>
<p><span>-all available beta lactam antibiotics (except two new cephalosporins) fail to bind to MRSA’s new PBP (PBP2a)</span></p>
<p><span>-</span>MRSA is currently treatable with vancomycin, daptomycin and ceftaroline</p>
<p><span>Which class of beta lactam antibiotics has the broadest spectrum of activity?</span></p>
<p><span>Carbapenems (-penem): Imipenem, Meropenem</span></p>
<p><span>Which 1 class of beta lactams antibiotics has activity against gram negative bacteria only?</span></p>
<p><span>Monobactams: Aztreonam (</span><span>gram negative</span><span> only)</span></p>
<p><span>Among the 4 categories of penicillins, which 2 have a narrow spectrum of activity, and which 1 has the broadest spectrum of activity?</span></p>
<ol><li><span><strong>Narrow spectrum</strong>:</span><ol><li><span><u>Natural Penicillins</u>: Penicillin G (IV), Penicillin V (PO)</span></li><li><span><u>Anti-Staphylococcal</u>: Naficillin and Oxacillin (IV), Dicloxcillin (PO)</span></li></ol></li><li><span><strong>Broadest spectrum</strong>:</span><ol><li><span><u>Extended Spectrum</u>: Piperacillin + tazobactam (IV/IM)</span></li></ol></li></ol>
<p><span>All penicillins have activity against which type of bacteria – gram positive or gram negative?</span></p>
<p><span>Gram Positive!</span></p>
<p><span>Name 6 antibiotic classes / subclasses / drugs that can be used to treat MDR strains of bacteria</span></p>
<ol>
<li><span><u>Cephalosporins</u> (5th generation, IV): Ceftaroline, ceftolozane + tazobactam</span></li>
<li><span><u>Carbapenems</u>: Imipenem (combine with<strong>beta-lactam inhibitor</strong> to provide activity against MDR bacteria)</span></li>
<li><span><u>Glycopeptide</u>: Vancomycin (more use recently due to rise in MDR bacteria)</span></li>
<li><span><u>Other cell wall agents</u>: Fosfomycin</span></li>
<li><span><u>Cell membrane agents</u>: Polymyxins</span></li>
<li><span>Daptomycin (Lipopeptide - cell membrane agent)</span></li>
</ol>
<p><span>Which of the β lactams is least likely to have cross-reactivity in patients with penicillin allergy?</span></p>
<p><span><u>Monobactams</u>: Aztreonam (NO CROSS REACTIVITY)</span></p>
<p><span>Which β lactam drug class is associated with the highest risk of C difficile colitis?</span></p>
<p><span><u>Cephalosporins (3rd generation)</u>: cefitu<strong>ten</strong> (PO), cefotax<strong>ime</strong>, ceftriax<strong>one</strong> (-one, -ten, -ime)</span></p>
<p><span>Which antibiotic drug produces a classic constellation of side effects including histamine-mediated flushing, ototoxicity and nephrotoxicity?</span></p>
<p><span><u>Glycopeptides:</u> Vancomycin</span></p>
<p><span>Which β lactam subclass can cause alcohol intolerance, hemolysis, impaired coagulation and<i> C diff.</i>colonic overgrowth?</span></p>
<p><span>Cephalosporins (3rd generation): cefitu<strong>ten</strong> (PO), cefotax<strong>ime</strong>, ceftriax<strong>one</strong> (-one, -ten, -ime)</span></p>
<p><span>Which β lactam drug is mainly cleared by renal metabolism?</span></p>
<p><span><u>Carbapenems (-penem)</u>:<strong>Imipenem</strong>, Merapenem, Doripenem, Ertapenem</span></p>